Phoenix Life Sciences International Announces Angus Stewart as Company's New Agriculture and Horticulture Senior Advisor
November 28 2018 - 09:55AM
InvestorsHub NewsWire
Phoenix Life Sciences
International Announces Angus Stewart as Company’s New Agriculture
and Horticulture Senior Advisor
Denver, CO -- November 28, 2018 -- InvestorsHub NewsWire --
Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”), an
international adaptive healthcare solutions company, today
announced that Angus Stewart has joined the company as the
Agriculture and Horticulture Senior Advisor.
Angus Stewart has over two decades of experience specializing in
horticulture and is currently an Agricultural and Horticultural
Scientist and Consultant Plant Breeder of approximately 100
commercially released plant cultivars. He is an Honorary Research
Associate at the University of Tasmania and has been involved in
multiple significant studies including several on the benefits of
cannabidiol (CBD). Additionally, Stewart has extensive experience
with plant breeding techniques of all levels and is well versed in
the best practices for the production and extraction of botanical
active ingredients like cannabinoids.
“As Phoenix Life Sciences International continues to expand its
reach to help more patients in need, we are proud to add such a
well-respected horticulturist like Angus Stewart to the team,” said
Phoenix Life Sciences International CEO Martin Tindall. “We are
excited to have such highly-skilled and passionate advisors joining
with us to achieve our mission of shifting global healthcare.”
Stewart is the recipient of the Outstanding Contribution to
Horticulture Award and the Allan Seale Award for Services from the
New South Wales, Australia Nursery and Garden Industry Association.
He is a published author and has written several papers and books
on plant propagation and gardening. He has already created a
production plan for the 50 acres of medicinal cannabis Phoenix Life
plans to cultivate in the new year.
“After thorough research into the benefits of medical cannabis and
botanical pharmaceuticals, I am excited to join Phoenix Life
Sciences’ mission of transforming the future of global healthcare,”
said Angus Stewart. “I believe that my expertise will allow me to
help cultivate the best ingredients for the many pharmaceutical
products the company intends to offer.”
To learn more about Phoenix Life Sciences International, please
visit https://plsi.co/#about.
About Phoenix Life Sciences International
Limited
Phoenix Life Sciences International Limited is an adaptive
healthcare solutions company. Our business is to advance research
and integrate programs and manufacturing of products that target
and treat diabetes, pain, cancer, and address psychological,
gastrointestinal, autoimmune, neurological and sleep disorders. We
strive to create partnerships and integrate these programs for
human health into communities worldwide as part of our Global
Health Initiative.
FORWARD-LOOKING STATEMENTS
Information contained in this press release regarding
Phoenix Life Sciences International Limited and its subsidiaries,
(the “Companies”) may constitute forward-looking statements or
statements which may be deemed or construed to be forward-looking
statements. The words “plan”, “forecast”, “anticipates”,
“estimate”, “project”, “intend”, “expect”, “should”, “believe,” and
similar expressions are intended to identify forward-looking
statements. These forward-looking statements involve, and are
subject to, known and unknown risks, uncertainties and other
factors which could cause the Company’s actual results, performance
(financial or operating) or achievements to differ from the future
results, performance (financial or operating) or achievements
expressed or implied by such forward-looking statements. The risks,
uncertainties and other factors are more fully discussed in the
Company’s filings with the U.S. Securities and Exchange Commission.
All forward-looking statements attributable to the Companies herein
are expressly qualified in their entirety by the above-mentioned
cautionary statement. The Companies disclaim any obligation to
update forward-looking statements contained in this press release,
except as may be required by law.
FOOD AND DRUG ADMINISTRATION (FDA)
DISCLOSURE
These statements have not been evaluated by the FDA and
therefore the products sold by Phoenix Life Sciences International
are not available on U.S.
LEGAL DISCLOSURE
Phoenix Life Sciences International does not sell or distribute
any products in the United States that are in violation of the
United States Controlled Substances Act (US.CSA). This company does
not grow, sell, and distribute cannabis-based products in the
United States and is solely involved with the legal distribution of
medical cannabis-based products within certain international
markets outside of the United States.
Investor Contact:
Phone: 1.888.717.5655 or international +1.720.699.7222
E-mail: investor.relations@phoenixlife.co
Media Contact:
Kathryn Reinhardt
CMW Media
Kathryn@cmwmedia.com
619-972-3089
Source: Phoenix Life Sciences International
Phoenix Life Sciences (CE) (USOTC:PLSI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Phoenix Life Sciences (CE) (USOTC:PLSI)
Historical Stock Chart
From Mar 2023 to Mar 2024